Redcare Pharmacy NV (RDC.DE)

EUR 139.9

(-3.38%)

Gross Profit Summary of Redcare Pharmacy NV

Redcare Pharmacy NV's latest annual gross profit in 2023 was 440.38 Million EUR , up 15.46% from previous year.
Redcare Pharmacy NV's latest quarterly gross profit in 2024 Q1 was 114.56 Million EUR , up 11.52% from previous quarter.
Redcare Pharmacy NV reported a annual gross profit of 331.78 Million EUR in annual gross profit 2022, up 24.48% from previous year.
Redcare Pharmacy NV reported a annual gross profit of 266.52 Million EUR in annual gross profit 2021, up 21.41% from previous year.
Redcare Pharmacy NV reported a quarterly gross profit of 114.05 Million EUR for 2024 Q2, down -0.45% from previous quarter.
Redcare Pharmacy NV reported a quarterly gross profit of 103.08 Million EUR for 2023 Q1, up 13.0% from previous quarter.

Annual Gross Profit Chart of Redcare Pharmacy NV (2023 - 2013)

Historical Annual Gross Profit of Redcare Pharmacy NV (2023 - 2013)

Year	Gross Profit	Gross Profit Growth
2023	440.38 Million EUR	15.46%
2022	331.78 Million EUR	24.48%
2021	266.52 Million EUR	21.41%
2020	219.52 Million EUR	59.45%
2019	137.68 Million EUR	38.63%
2018	99.31 Million EUR	72.48%
2017	57.58 Million EUR	58.71%
2016	36.28 Million EUR	40.97%
2015	25.73 Million EUR	42.71%
2014	18.03 Million EUR	41.48%
2013	12.74 Million EUR	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	114.56 Million EUR	11.52%
2024 Q2	114.05 Million EUR	-0.45%
2023 Q1	103.08 Million EUR	13.0%
2023 Q3	109.4 Million EUR	2.65%
2023 Q2	106.57 Million EUR	3.38%
2023 Q4	102.73 Million EUR	-6.1%
2023 FY	383.09 Million EUR	15.46%
2022 Q3	79.82 Million EUR	0.07%
2022 Q4	91.23 Million EUR	14.3%
2022 FY	331.78 Million EUR	24.48%
2022 Q1	80.96 Million EUR	14.15%
2022 Q2	79.76 Million EUR	-1.49%
2021 Q1	72.85 Million EUR	16.25%
2021 Q2	63.4 Million EUR	-12.96%
2021 Q3	59.34 Million EUR	-6.41%
2021 FY	266.52 Million EUR	21.41%
2021 Q4	70.93 Million EUR	19.53%
2020 Q3	52.37 Million EUR	-4.02%
2020 FY	219.52 Million EUR	59.45%
2020 Q4	62.66 Million EUR	19.64%
2020 Q2	54.57 Million EUR	9.34%
2020 Q1	49.91 Million EUR	31.27%
2019 Q2	34.74 Million EUR	6.52%
2019 FY	137.68 Million EUR	38.63%
2019 Q1	32.61 Million EUR	18.68%
2019 Q4	38.02 Million EUR	17.72%
2019 Q3	32.3 Million EUR	-7.03%
2018 Q4	27.48 Million EUR	8.17%
2018 FY	99.31 Million EUR	72.48%
2018 Q1	23.01 Million EUR	35.46%
2018 Q2	23.41 Million EUR	1.73%
2018 Q3	25.4 Million EUR	8.52%
2017 Q1	13.23 Million EUR	23.33%
2017 Q2	13.98 Million EUR	5.71%
2017 Q4	16.99 Million EUR	27.01%
2017 Q3	13.37 Million EUR	-4.35%
2017 FY	57.58 Million EUR	58.71%
2016 Q4	10.72 Million EUR	23.49%
2016 Q3	8.68 Million EUR	2.49%
2016 Q2	8.47 Million EUR	1.01%
2016 Q1	8.39 Million EUR	27.78%
2016 FY	36.28 Million EUR	40.97%
2015 Q1	6.35 Million EUR	0.0%
2015 FY	25.73 Million EUR	42.71%
2015 Q2	6.35 Million EUR	0.0%
2015 Q4	6.56 Million EUR	1.51%
2015 Q3	6.46 Million EUR	1.87%
2014 FY	18.03 Million EUR	41.48%
2013 FY	12.74 Million EUR	0.0%

Peer Gross Profit Comparison of Redcare Pharmacy NV

Name	Gross Profit	Gross Profit Difference
Newron Pharmaceuticals S.p.A.	9.05 Million EUR	-4762.35%